12th World Clinical Biomarkers & CDx Summit

Returning to its home-ground in Boston, the 12^th World CB & CDx Summit is back at a pivotal time for precision medicine! Join your dedicated community as we explore biomarker discovery through to commercialization alongside a diagnostic to deliver safe and effective precision & targeted therapies to more patients with maximised global access.

You can visit the Mission Bio team at Booth #26, and on September 28th at 4:15 PM, be sure to catch “Clonal evolution underlying clinical responses and relapses in patients with IDH1-mutated AML treated with ivosidenib monotherapy or ivosidenib + azacitidine,” presented by Dylan Marchione, PhD, of Servier Pharmaceuticals.